IMDELLTRA
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IMDELLTRA, covering 2024-05-16 to 2025-11-19. Get the full timeline:
Most recent: FDA Approved: IMDELLTRA (AMG757) — Supplemental Application (Amgen, Inc)